| CAS No 3107-98-0 |
dimethyl octafluoroadipatenull |
Inquiry |
| CAS No 307-79-9 |
Decanoic acid,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-nonadecafluoro-, methyl esternull |
Inquiry |
| CAS No 307-34-6 |
n-Perfluorooctanenull |
Inquiry |
| CAS No 307-46-0 |
1-Undecanol,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heneicosafluoro-null |
Inquiry |
| CAS No 30377-52-7 |
Nonanoic acid,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluoro-, ethyl esternull |
Inquiry |
| CAS No 2991-28-8 |
2,5-Difluorobenzoic acidnull |
Inquiry |
| CAS No 2995-45-1 |
3-(trifluoromethoxy)nitrobenzenenull |
Inquiry |
| CAS No 29463-77-2 |
2-Propanol,hexafluoro- (8CI,9CI)null |
Inquiry |
| CAS No 2923-56-0 |
4-(Trifluoromethyl)phenylhydrazine hydrochloridenull |
Inquiry |
| CAS No 2926-27-4 |
Potassium trifluoromethanesulfonatenull |
Inquiry |
| CAS No 28781-85-3 |
2,2-Difluoropropionic acid ethyl esternull |
Inquiry |
| CAS No 2822-41-5 |
2,3,4-Trifluorophenolnull |
Inquiry |
| CAS No 27704-96-7 |
Propanoic acid,2-bromo-3-methoxy-, methyl esternull |
Inquiry |
| CAS No 2713-34-0 |
3,5-Difluorophenolnull |
Inquiry |
| CAS No 2706-90-3 |
perfluorovaleric acidnull |
Inquiry |
| CAS No 25366-22-7 |
1,3,4-Thiadiazol-2-amine,N-methyl-5-(trifluoromethyl)-null |
Inquiry |
| CAS No 26885-71-2 |
1-Propene,3,3,3-trifluoro-1-methoxy-, (1E)-null |
Inquiry |
| CAS No 244022-64-8 |
Propanedioic acid,2-(4,4,5,5,6,6,6-heptafluorohexyl)-null |
Inquiry |
| CAS No 243128-46-3 |
Piperazine, 1-(4-fluoro-2-nitrophenyl)-null |
Inquiry |
| CAS No 243139-71-1 |
2,4,5-Trifluorobenzyl chloridenull |
Inquiry |
| CAS No 242142-82-1 |
1-Octadecanol,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-pentatriacontafluoro-null |
Inquiry |
| CAS No 2367-82-0 |
1,2,3,5-tetrafluorobenzenenull |
Inquiry |
| CAS No 2374-14-3 |
1,3,5-tris(3,3,3-trifluoropropyl)methylcyclotrisiloxanenull |
Inquiry |
| CAS No 2366-70-3 |
4,4,4-trifluorobutan-2-onenull |
Inquiry |
| CAS No 2356-57-2 |
Ethane,1,2-dibromo-1,1,2-trifluoro-2-(trifluoromethoxy)-null |
Inquiry |
